Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases

Anna Mae Diehl, Patricia Latham, John K. Boitnott, John Mann, Willis C. Maddrey

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Cholestatic hepatitis developed in two patients while they were receiving erythromycin ethylsuccinate. Both patients had received the drug without apparent problem within two months of the episode of drug-related Cholestatic injury. In both, there was complete resolution of the hepatic injury upon withdrawal of the drug. Erythromycin ethylsuccinate should be added to the list of drugs causing Cholestatic hepatitis.

Original languageEnglish (US)
Pages (from-to)931-934
Number of pages4
JournalThe American Journal of Medicine
Issue number5
StatePublished - May 1984

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cholestatic hepatitis from erythromycin ethylsuccinate report of two cases'. Together they form a unique fingerprint.

Cite this